How to Buy Xtant Medical Holdings Stock
Xtant Medical Holdings Inc
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures.
Xtant Medical Holdings stock last closed at $0.78, down 0.63% from the previous day, and has increased 30.88% in one year. It has overperformed other stocks in the Medical Devices industry by 0.47 percentage points. Xtant Medical Holdings stock is currently +30.88% from its 52-week low of $0.60, and -45.93% from its 52-week high of $1.45.
At the moment, there are 130.22M XTNT shares outstanding. The market value of XTNT is $102.09M. In the past 24 hours, 183,921 XTNT shares were traded.
How to Buy Xtant Medical Holdings Stock
Wondering how to invest in Xtant Medical Holdings stock? Here's how.
- Choose where to buy Xtant Medical Holdings stock: You need to pick an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you decide where to buy Xtant Medical Holdings stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Fund your brokerage account: Select your payment method and add your info.
- Research Xtant Medical Holdings stock: The Xtant Medical Holdings ticker symbol is XTNT. Is Xtant Medical Holdings stock a good investment? Should you buy shares of XTNT? How do XTNT's underlying business fundamentals look? Do top analysts think Xtant Medical Holdings is a good buy? Why has XTNT's stock price moved recently? (Hint: Our stock research tools can help you figure out if XTNT is a good stock to buy).
- Execute your XTNT trade: Decide if you will purchase XTNT shares at the current market price or use a limit order to buy XTNT shares at a given price.
- Track your investment in XTNT: Create a watchlist to important notifications about your new investment in Xtant Medical Holdings shares.
Step 1: Choose where to buy Xtant Medical Holdings stock
You need a brokerage account in order to access the NYSEMKT market and buy XTNT shares.
Our favorite brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world markets: From Technology to Industrials, New York to Tokyo — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro today.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've selected the best brokerage, the next step is to fill out some personal information so you are able to buy XTNT stock today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create a new brokerage account.
- Submit your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you've created your account on the best investment app, you can securely and quickly fund your account:
Check out the video below to see the process of transferring money into your new investment account.
Step 4: Research Xtant Medical Holdings stock
After you have chosen the best place to buy Xtant Medical Holdings stock, it's absolutely critical to research their stock before you buy, so you can comprehend the risk and upside.
Xtant Medical Holdings stock quick numbers
XTNT Overview
WallStreetZen was created to help average investors perform better fundamental analysis.
You can see all of the due diligence checks on XTNT's stock page.
How is XTNT stock valued?
You can use many financial metrics, analyses, models, and charts to gauge XTNT's true value.
Using relative valuations methods:
- XTNT could be overvalued based on its P/E ratio of 78.4x, relative to Medical Devices industry P/E ratio of 28.84x
- XTNT may be undervalued based on its P/B ratio of 1.99x, relative to Medical Devices industry P/B ratio of 3.66x
You can access more valuation analysis on XTNT's stock here.
A quick look at XTNT Financials
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the XTNT balance sheet.
- XTNT profit margin has gone up from -14.6% to 0.7% in the past year.
- There are more short-term assets than long-term liabilities on the XTNT balance sheet.
- Total XTNT debt is lower than 5 years ago, relative to shareholder equity.
Negative Health Checks:
- XTNT has a relatively high debt to equity ratio of 0.8.
- XTNT has $5.92M in cash and short term investments. This is not sufficient to cover its annual cash burn of $10.80M.
- XTNT has cash burn of 10796000. It does not have sufficient cash and short-term investments to cover this.
Is Xtant Medical Holdings stock a Buy, Hold, or Sell, according to analysts?
Out of 1 Equities analysts who track XTNT, the consensus analyst rating on XTNT is a Strong Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Xtant Medical Holdings stock forecast page.
XTNT Trading Indicators
Is XTNT Growing Revenue?
Last year, XTNT revenue was $91.30M. Over the past 5 year, XTNT's revenue has gone up by 4.81% per year. This was slower than the Medical Devices industry average of 13.45%.
Dig into XTNT's earnings and revenue performance here.
Are XTNT insiders buying or selling the stock?
Over the past year, executives and large shareholders at XTNT have sold more shares than they have bought.
Scott C. Neils, Chief Financial Officer of XTNT, was the latest XTNT insider to sell. They sold $8,704.74 worth of XTNT shares on Jan 16, 2024.
Dig into more about who owns XTNT stock here.
Can I get consistent income from XTNT stock?
No, Xtant Medical Holdings doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your XTNT trade
You have two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly the best for newer investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a particular dollar amount, use a limit order.
Click the Open button and your broker will place the order.
If you need more help buying stocks on eToro, watch the helpful video below:
Step 6: Track your investment in XTNT
Now that you own some XTNT shares, you'll want to keep up with your new company.
Create a watchlist to track your XTNT stock.
XTNT Feed
No news
There is no news on the companies in your watchlist or you don't have enough companies added to your list.
How to Buy Stock in Xtant Medical Holdings
To reiterate, here are the 6 steps for buying Xtant Medical Holdings stock:
- Choose where to buy Xtant Medical Holdings stock
- Sign up for a brokerage account
- Fund your brokerage account
- Research Xtant Medical Holdings stock
- Execute your XTNT trade
- Track your investment in XTNT
If you need a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Xtant Medical Holdings, add XTNT to your watchlist below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.